Posted:
9/12/2024, 8:53:03 AM
Location(s):
Massachusetts, United States ⋅ Boston, Massachusetts, United States
Experience Level(s):
Senior
Field(s):
Accounting
Workplace Type:
Remote
Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with cancer. Scorpion has built a proprietary and fully integrated platform of the most advanced technologies across cancer biology, medicinal chemistry, and data sciences, with the goal of consistently and rapidly creating exquisitely selective small molecule compounds against an unprecedented spectrum of targets. Scorpion aims to leverage its platform to advance a broad pipeline of wholly owned, optimized compounds across three target categories: best-in-class molecules targeting validated oncogene targets; first-in-class molecules for previously undruggable targets; and first-in-class molecules for novel cancer targets.
Job Title: Contract Accounts Payable Specialist/Sr. Accounts Payable Specialist
Company: Scorpion Therapeutics
Location: Boston, MA
Contract Length: 3 Months
Weekly Hours: 40 hours/week
Pay: $30-$50/hr
Job Summary:
We are seeking a highly organized, detail-oriented, and proactive Accounts Payable Specialist/Sr. Accounts Payable Specialist with high-volume invoicing and NetSuite experience to join our Finance team on a 3-month contract basis. This role is ideal for focused, high-energy individuals who thrive within a fast-paced and collaborative environment.
Key Responsibilities:
Qualifications:
Scorpion Therapeutics Inc. is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Website: https://scorpiontx.com/
Headquarter Location: Boston, Massachusetts, United States
Employee Count: 11-50
Year Founded: 2020
IPO Status: Private
Last Funding Type: Series B
Industries: Biotechnology ⋅ Health Care ⋅ Life Science ⋅ Oncology ⋅ Precision Medicine